lafutidine inn second generation histamine receptor antagonist multimodal mechanism action used treat gastrointestinal marketed south korea japan india lafutidine used treat gastric ulcers duodenal ulcers well wounds lining stomach associated acute gastritis acute exacerbation chronic adverse events observed clinical trials included constipation diarrhea drug rash nausea vomiting like receptor antagonists lafutidine acts preventing secretion gastric also activates calcitonin generelated peptide resulting stimulation nitric oxide regulation gastric mucosal blood flow increases somatostatin levels also resulting less gastric acid secretion causes stomach lining generate mucin inhibits neutrophil activation thus preventing injury inflammation blocks attachment helicobacter pylori gastric marketed japan stogar india lafaxid zuventus also marketed south korea ildong lafutidine ildong pharmaceutical co ltd httpsenwikipediaorgwikilafutidine